iHear MatriX vs Lexie B3

The iHear MatriX is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.8/5, placing it in the top 40% of the OTC hearing aid category in our lab testing. At $499, this behind-the-ear device delivers solid speech performance that exceeds category averages, though with a notable tradeoff in streaming capabilities. Speech clarity is a clear strength for the MatriX. In quiet environments, it scores 4.0/5—a solid result that sits 1.17 points above the OTC category average. Speech in noise performance is more modest at 2.4/5, which is mixed in absolute terms but still 0.96 points above the typical OTC device. Feedback handling is excellent at 5.0/5, meaning users should experience minimal whistling during daily wear. The most significant limitation is music streaming, which scores 0.0/5—well below the category average of 1.92/5. While the MatriX supports both iPhone and Android streaming, audio fidelity for music is poor in our testing. Own-voice comfort is mixed at 2.7/5, roughly in line with category norms. The MatriX shows meaningful improvement with tuning, jumping from an Initial Score of 3.7/5 to a Tuned Score of 4.2/5. This suggests users who invest time in adjustment can unlock better performance. For budget-conscious buyers prioritizing speech understanding over music quality, the MatriX offers competitive value in its price range, though alternatives like the Elehear Beyond score higher overall at similar pricing.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.